UNICEF and the WHO Collaborating Centre for Maternal and Child Health (Trieste, Italy) are conducting a Europe-wide study to identify best practices and enabling policies supporting children’s and adolescents’ mental health across the EU Member States, the United Kingdom, Norway and Iceland
This initiative forms part of the European Commission–UNICEF three-year partnership to promote a comprehensive, prevention-oriented approach to children’s health
The project will result in the development of a Toolkit for Child and Adolescent Health and Mental Wellbeing Promotion, designed to support policymakers in strengthening national strategies and cross-sector collaboration.
To support EU Member States in improving child and adolescent health and wellbeing, the European Commission’s Directorate-General for Health and Food Safety (DG SANTE) and UNICEF are partnering in a three-year project that will focus on different aspects of children’s health including the promotion of good mental health. This initiative will generate evidence on the needs, constraints, barriers and gaps in policies, interventions and programmes across the 27 EU member states, Iceland, Norway and the United Kingdom, and develop a Toolkit to improve Child and Adolescent Health and Mental Wellbeing. The process will be accompanied and supported by Policy Dialogues enabling exchange and learning among member states.
Completing this survey will take approximately 45 minutes.
The information on the practices collected through this survey will be analysed by UNICEF and the WHO Collaborating Centre. By answering this survey you allow UNICEF and WHO Collaborating Centre to analyse the data provided, and to report it for the purpose of this project.
As part of this work, UNICEF, in collaboration with the WHO Collaborating Centre for Maternal and Child Health Trieste, Italy (WHO CC), is gathering information and resources on practices and policies supporting children’s and adolescents’ mental wellbeing, with the aim of identifying best practices to be included in the Toolkit.
Areas of particular interest emerging from the first policy dialogues with countries
You may report more than one practice.
You may upload files (reports, etc) and provide links
Send us an email (you can write us on more than one practice)
Attach a comprehensive report OR/AND
Provide us with a website where we can find comprehensive information OR/AND
Download and complete the template,
Please send materials to: [email protected];
New ways to test high-risk medical devices.
Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.
It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.
